Dr. Cyrus Desouza, MBBS, talks about why he is waiting a little longer before regularly prescribing sodium glucose cotransporter 2 (SGLT2) inhibitors. As an endocrinologist, he feels that, because he deals with very ill patients, it is incumbent upon him that he must also be more careful using a new drug.

Dr. Cyrus Desouza, MBBS, talks about the newest drug class, the sodium glucose cotransporter 2 (SGLT2) inhibitors. He does not regularly prescribe them at this point but if a patient requests a drug he will always research it. He will then discuss the drug and its side effects with his …

Dr. Cyrus Desouza, MBBS, reveals the dark secret behind why patients still use sulfonylureas. Although very effective inititally, the drug is only effective for a limited amount of time and there is beta cell burnout. Dr. Desouza tries not to start patients on sulfonylureas as a second-line; instead he’d rather start with basal …

Dr. Cyrus Desouza, MBBS, talks about the GLP-1s, of which several are already in the market with more in the pipeline. He believes that his is really an exciting class of drugs, particularly because of the weight loss effect, which is a big deal for patients. In addition, there may be …

Dr. Cyrus Desouza, MBBS, discusses cycloset, a new formulation of bromocriptine which has actually been around a long time. It has a similar story to metformin in that it’s been around a while so part of the reason it’s not more prescribed, he believes, is because it’s not a brand-new drug. Cycloset is …

Dr. Cyrus Desouza, MBBS, gives us some insight into how to promote better care and lifestyle changes in our patients. Improving patient participation and encouraging them to care for their own disease is key. Peer support has been known to improve diabetes patients’ health as well as group clinics, peer counseling, and having diabetes …

Dr. Cyrus Desouza, MBBS, discusses Shared Medical Appointments (SMA’s), how he has been able to use them in his practice for over ten years, and some of the benefits, including peer-to-peer counseling. He also answers questions about the challenges, including meeting certain parameters, which some medical offices who might want …

Dr. Cyrus Desouza, MBBS, reveals the most interesting new thing about diabetes treatment. Between the 1930’s and the year 2000 there were basically two diabetes drugs developed including insulin and metformin. That has changed dramatically and soon, patient treatment could involve much more tailored care….

We know that type 1 diabetes results from T-cell–mediated destruction of beta-cells in the pancreas. So, to prevent type 1 diabetes from developing, we need to stop that destruction. In addition to our quest to eliminate type 1, we need to preserve the remaining cells as well as generate new …

  In this week’s set of Homerun Slides, we delve in to what happens when blood sugar levels increase, the prevalence of prediabetes in our culture today, and some of the possible strategies and research investigating the prevention of diabetes, including the Diabetes Prevention Program….